Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute (RKI), Seestr. 10, 13353 Berlin, Germany
Martin B. Dorner
Biological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute (RKI), Seestr. 10, 13353 Berlin, Germany
Cécile Feraudet-Tarisse
Medicines and Healthcare Technologies Department (DMTS), Paris-Saclay University, French Alternative Energies and Atomic Energy Commission (CEA), INRAE, SPI, 91191 Gif-sur-Yvette, France
Christopher Pöhlmann
Bruker Daltonik GmbH, Permoserstr. 15, 04318 Leipzig, Germany
Katharina Schulz
Bruker Daltonik GmbH, Permoserstr. 15, 04318 Leipzig, Germany
Ute Messelhäußer
Bavarian Health and Food Safety Authority, Veterinärstr. 2, 85764 Oberschleißheim, Germany
Dagmar Rimek
Thuringian State Authority for Consumer Protection, Tennstedter Straße 8/9, 99947 Bad Langensalza, Germany
Bruker Daltonik GmbH, Permoserstr. 15, 04318 Leipzig, Germany
Stéphanie Simon
Medicines and Healthcare Technologies Department (DMTS), Paris-Saclay University, French Alternative Energies and Atomic Energy Commission (CEA), INRAE, SPI, 91191 Gif-sur-Yvette, France
Clostridium perfringens enterotoxin (CPE) regularly causes food poisoning and antibiotic-associated diarrhea; therefore, reliable toxin detection is crucial. To this aim, we explored stationary and mobile strategies to detect CPE either exclusively by monoclonal antibodies (mAbs) or, alternatively, by toxin-enrichment via the cellular receptor of CPE, claudin-4, and mAb detection. Among the newly generated mAbs, we identified nine CPE-specific mAbs targeting five distinct epitopes, among them mAbs recognizing CPE bound to claudin-4 or neutralizing CPE activity in vitro. In surface plasmon resonance experiments, all mAbs and claudin-4 revealed excellent affinities towards CPE, ranging from 0.05 to 2.3 nM. Integrated into sandwich enzyme-linked immunosorbent assays (ELISAs), the most sensitive mAb/mAb and claudin-4/mAb combinations achieved similar detection limits of 0.3 pg/mL and 1.0 pg/mL, respectively, specifically detecting recombinant CPE from spiked feces and native CPE from 30 different C. perfringens culture supernatants. The implementation of mAb- and receptor-based ELISAs into a mobile detection platform enabled the fast detection of CPE, which will be helpful in clinical laboratories to diagnose diarrhea of assumed bacterial origin. In conclusion, we successfully employed an endogenous receptor and novel high affinity mAbs for highly sensitive and specific CPE-detection. These tools will be useful for both basic and applied research.